WO1997004745A3 - Ophthalmologische zusammensetzung zum schutz vor augenirritationen, die durch ozon- oder/und uv-strahlung hervorgerufen werden - Google Patents

Ophthalmologische zusammensetzung zum schutz vor augenirritationen, die durch ozon- oder/und uv-strahlung hervorgerufen werden Download PDF

Info

Publication number
WO1997004745A3
WO1997004745A3 PCT/EP1996/003277 EP9603277W WO9704745A3 WO 1997004745 A3 WO1997004745 A3 WO 1997004745A3 EP 9603277 W EP9603277 W EP 9603277W WO 9704745 A3 WO9704745 A3 WO 9704745A3
Authority
WO
WIPO (PCT)
Prior art keywords
ozone
eyes
radiation
protecting
irritation caused
Prior art date
Application number
PCT/EP1996/003277
Other languages
English (en)
French (fr)
Other versions
WO1997004745A2 (de
Inventor
Otto Schmut
Original Assignee
Laevosan Gmbh & Co Kg
Otto Schmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laevosan Gmbh & Co Kg, Otto Schmut filed Critical Laevosan Gmbh & Co Kg
Priority to AU67370/96A priority Critical patent/AU6737096A/en
Publication of WO1997004745A2 publication Critical patent/WO1997004745A2/de
Publication of WO1997004745A3 publication Critical patent/WO1997004745A3/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Zum Schutz vor Augenirritationen und Erkrankungen des äußeren Auges, welche durch Ozon oder/und UV-Strahlung hervorgerufen werden, verwendet man eine ungesättigte Komponente, umfassend Lipide, Fettsäuren und Ester mit einer Jodzahl > 100 oder Gemische davon. Eine geeignete Zusammensetzung ist eine isotone, gepufferte Öl-in-Wasser-Emulsion, welche die ungesättigte Komponente in einer Menge von 2 Gew.-% bis 50 Gew.-%, Phospholipid in einer Menge von 0,1 Gew.-% bis 10 Gew.-% und bevorzugt nicht-oberflächenaktives Verdickungsmittel in einer Menge von 0,01 Gew.-% bis 1 Gew.-% jeweils bezogen auf das Gesamtgewicht der Emulsion umfaßt.
PCT/EP1996/003277 1995-07-25 1996-07-25 Ophthalmologische zusammensetzung zum schutz vor augenirritationen, die durch ozon- oder/und uv-strahlung hervorgerufen werden WO1997004745A2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU67370/96A AU6737096A (en) 1995-07-25 1996-07-25 Ophthalmological composition for protecting the eyes from irritation caused by ozone and/or uv radiation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19527132.7 1995-07-25
DE1995127132 DE19527132A1 (de) 1995-07-25 1995-07-25 Ophthalmologische Ozonschutzzusammensetzung

Publications (2)

Publication Number Publication Date
WO1997004745A2 WO1997004745A2 (de) 1997-02-13
WO1997004745A3 true WO1997004745A3 (de) 1997-03-27

Family

ID=7767729

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1996/003277 WO1997004745A2 (de) 1995-07-25 1996-07-25 Ophthalmologische zusammensetzung zum schutz vor augenirritationen, die durch ozon- oder/und uv-strahlung hervorgerufen werden

Country Status (3)

Country Link
AU (1) AU6737096A (de)
DE (1) DE19527132A1 (de)
WO (1) WO1997004745A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1020194A4 (de) * 1997-10-01 2003-05-21 Wakamoto Pharma Co Ltd Öl/wasser emulsion zusammenstellungen
CN100464786C (zh) * 2003-09-10 2009-03-04 千寿制药株式会社 隐形眼镜用眼科用组合物
FR2962044B1 (fr) * 2010-04-21 2013-02-22 Horus Pharma Emulsion lacrymimetique
EP2667852B1 (de) * 2011-01-27 2016-11-09 GlaxoSmithKline Biologicals SA Adjuvante nanoemulsionen mit kristallisationsinhibitoren

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR707525A (fr) * 1930-04-14 1931-07-09 Ecran protecteur contre les rayons ultra-violets
EP0253472A1 (de) * 1986-05-16 1988-01-20 Green Cross Corporation Flurbiprofen enthaltende Ophthalmika Zubereitung
US4923693A (en) * 1988-01-21 1990-05-08 Sundrops Enterprises, Inc. Ultraviolet radiation screening method for eyes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE132366T1 (de) * 1990-05-29 1996-01-15 Boston Ocular Res Zusammensetzung zur behandlung von dry eye erkrankungen
IL98747A0 (en) * 1991-07-05 1992-07-15 Yissum Res Dev Co Ophthalmic compositions
CA2142103C (en) * 1992-08-28 2003-07-08 Haim Aviv Submicron emulsions as ocular drug delivery vehicles
US5744155A (en) * 1993-08-13 1998-04-28 Friedman; Doron Bioadhesive emulsion preparations for enhanced drug delivery

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR707525A (fr) * 1930-04-14 1931-07-09 Ecran protecteur contre les rayons ultra-violets
EP0253472A1 (de) * 1986-05-16 1988-01-20 Green Cross Corporation Flurbiprofen enthaltende Ophthalmika Zubereitung
US4923693A (en) * 1988-01-21 1990-05-08 Sundrops Enterprises, Inc. Ultraviolet radiation screening method for eyes

Also Published As

Publication number Publication date
AU6737096A (en) 1997-02-26
DE19527132A1 (de) 1997-01-30
WO1997004745A2 (de) 1997-02-13

Similar Documents

Publication Publication Date Title
CA2218090A1 (en) Cleansing emulsions
CA2190485A1 (en) Lacrimal gland specific emulsions for topical application to ocular tissue
TW279801B (de)
CA2166204A1 (en) Pharmaceutical compositions for sparingly soluble therapeutic agents
CA2078990A1 (en) Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
AU6986096A (en) Oil-water emulsifiers
CA2125060A1 (en) Ophthalmic Solution for Artificial Tears
CA2026963A1 (en) Facial cleansing compositions
CA2107076A1 (en) Artificial Tanning Compositions Containing Positively Charged Paucilamellar Vesicles
CA2266723A1 (en) Liquid personal cleansing compositions which contain a lipophilic skin moisturizing agent comprised of relatively large droplets
HUT63942A (en) Insecticidal product comprising pyrethroid
CA2106176A1 (en) Neutral lipids from kernel of job's tears
KR100260061B1 (en) Vitamin e drop
ES2141736T3 (es) Gel, especialmente para uso terapeutico ocular.
WO1997004745A3 (de) Ophthalmologische zusammensetzung zum schutz vor augenirritationen, die durch ozon- oder/und uv-strahlung hervorgerufen werden
CA2020877A1 (en) Stable tretinoin emulsified cream formulations
PL300286A1 (en) Local application therapeutic agent for eyes ued in treatment of increased intraocular pressure
AU2774292A (en) Toiletries composition
FI980947A0 (fi) Zeaksantiinin puhdas 3R-3'R-stereoisomeeri silmän keltatäplämuutoksen hoitamiseksi
WO1999060948A3 (fr) Principe permettant de traiter des maladies oculaires
RU95110557A (ru) Препарат для диагностики заболеваний и травм роговой оболочки глаза
GT198274988A (es) Complejos de carboxilatos alcoxilados -- compuestos anfote ros que presentan propiedades de formacion de espuma conve nientes y baja irritacion ocular
KR970043003A (ko) 지방산, 요소, 아존 등의 피부 흡착 촉진제에 의해 피부미용 효과가 증진된 유기게르마늄을 함유하는 인체세정제 조성물
KR950026514A (ko) 프로폴리스 함유 피부용 세정제
CA2309033A1 (en) Lacrimal gland specific emulsions for topical application to ocular tissue

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA JP NO US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA JP NO US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: CA

122 Ep: pct application non-entry in european phase